Counterparty Due Diligence for Cross-Border Emerging Market Deals

You're looking at a deal in Nigeria, Vietnam, or Colombia. The local partner has a solid deck, credible references, and a bank relationship you recognize. Your lawyer says the structure is clean. And yet something nags at you—because you've never actually verified who you're dealing with at the entity level.

That nagging feeling is the right instinct. Cross-border emerging market deals fail for a lot of reasons: currency, regulation, execution. But a disproportionate share of the catastrophic failures—the ones that end in litigation, write-offs, or a FCPA inquiry—trace back to a counterparty problem that was findable before close.

This post is about how small and mid-sized funds vetting SME investments or partnership structures in emerging markets can run a disciplined counterparty check without hiring a Kroll team.

---

Why Emerging Markets Are a Distinct Problem

The standard playbook for domestic deals—pull a D&B report, Google the founder, check LinkedIn—doesn't travel well.

In many emerging markets, corporate registries are either incomplete, poorly maintained, or inaccessible to foreign researchers without a local fixer. Beneficial ownership disclosure requirements, even where mandated, are frequently unenforced. A company registered in Lagos, Ho Chi Minh City, or Bogotá may have perfectly legitimate operations and still produce almost no useful public record in English.

This creates two compounding risks:

1. You can't see what you don't know to look for. Adverse media exists in Portuguese, Bahasa, Yoruba-language outlets, and regional court databases you've never heard of. A company that looks clean in English-language search may have a well-documented fraud history in the local press.

2. Beneficial ownership chains are genuinely opaque. Shell layering across jurisdictions is not exotic—it's routine. A counterparty may be beneficially owned by a politically exposed person (PEP) or sanctioned individual several steps removed from the entity you're dealing with. Without digging into the ownership structure, you're underwriting a risk you can't see.

---

The Four Things You Need to Establish

Before any emerging market deal closes, you should be able to answer four questions with documented evidence—not gut feel.

1. Does this entity actually exist and in good standing?

This sounds basic. It isn't. Corporate registration fraud—presenting documents for entities that are dissolved, struck off, or simply fictional—is common enough in some markets that verification should be step zero, not an afterthought.

For jurisdictions with accessible registries, start with OpenCorporates, which aggregates public company records from over 140 jurisdictions. For markets where OpenCorporates has limited coverage, you'll need to go to the source: Nigeria's Corporate Affairs Commission (CAC), Vietnam's National Business Registration Portal, or Colombia's Cámara de Comercio de Bogotá, for example. If your local counsel can't pull a current certificate of good standing and a registered director list directly from the relevant authority, treat that as a red flag.

2. Who actually owns this entity?

Disclosed ownership and beneficial ownership are different things. The disclosed structure is what's on the registration documents. Beneficial ownership is who ultimately controls and benefits—which may be two or three layers up through holding companies in Mauritius, the BVI, or Cyprus.

The Financial Action Task Force (FATF) has published extensive guidance on beneficial ownership transparency deficiencies by country. If your counterparty is domiciled in or has significant ownership routed through a FATF grey-listed or black-listed jurisdiction, that's not disqualifying on its own—but it raises the required standard of evidence. You should expect to receive a corporate structure chart, shareholder registry, and evidence of the ultimate beneficial owner's identity. If that's hard to get, ask yourself why.

3. Are any principals or beneficial owners sanctioned or politically exposed?

This is the piece that creates the most legal exposure for a fund. Transacting with a sanctioned party—even inadvertently—can trigger OFAC liability, EU sanctions violations, or UK OFSI penalties. "We didn't know" is not an affirmative defense under strict liability regimes.

Sanctions lists to screen against include:

• OFAC SDN List (U.S.)
• EU Consolidated Financial Sanctions List
• UK OFSI Consolidated List
• UN Security Council Consolidated List

OpenSanctions consolidates many of these lists (plus PEP databases) into a single searchable dataset. It's free for non-commercial use and updated daily. For a fund, running every named principal through OpenSanctions before close should be a minimum standard—not a stretch goal.

PEP screening matters separately. A senior government official, state-owned enterprise executive, or close family member of either may not be sanctioned but still represents a heightened risk under anti-bribery frameworks like the U.S. Foreign Corrupt Practices Act (FCPA) or the UK Bribery Act 2010. Transacting with a PEP isn't prohibited—but it requires enhanced due diligence and documented rationale.

4. Is there adverse history you'd want to know about?

Lawsuits, regulatory actions, prior fraud allegations, association with failed or scandal-adjacent entities—these are findable, but not in one place.

For U.S.-listed entities or those with U.S. operations, SEC EDGAR and PACER are standard stops. For international coverage, World-Check and Dow Jones Risk & Compliance are the commercial standards—but both carry price points that don't make sense at the deal sizes most small funds work with.

For practical adverse media coverage in emerging markets, a structured search across local-language press is often more useful than any commercial database. This means searching in the local language, not just English. Google Translate is imperfect but sufficient for a first pass on whether a company name appears in the same sentence as words meaning "fraud," "arrest," "investigation," or "court."

---

Where Small Funds Typically Cut Corners—and Pay for It

There are three predictable failure modes in cross-border counterparty diligence at the fund level:

Delegating entirely to local counsel. Local counsel can confirm that documents are facially valid under local law. They typically cannot tell you that the beneficial owner is a government minister's cousin, or that the entity was involved in a procurement scandal three years ago. These are different skill sets. Use both.

Screening only the named entity, not the principals. Sanctions hits and adverse history attach to individuals as often as to entities. A company with a clean record may be owned by someone who doesn't have one. If you're only running the corporate name through a sanctions screen, you're doing half the job.

Treating the deck as the diligence. Management presentations are marketing documents. The counterparty has selected everything in them. Your job is to verify the claims they make, find the things they didn't mention, and document your process. "They seemed credible and the deck was solid" is not a defensible diligence file if the deal goes wrong.

---

A Practical Workflow for Funds Without a Full Compliance Team

You don't need a 12-person compliance function to do this properly. You need a consistent process and the right tools.

A reasonable baseline workflow for a cross-border SME counterparty check looks like this:

1. Entity verification. Pull the corporate registry record directly from the relevant authority or via OpenCorporates. Confirm registration status, directors, and registered address. Flag discrepancies against the counterparty's own documents.

2. Beneficial ownership mapping. Request a corporate structure chart and shareholder registry. For holding company layers, trace back to the ultimate beneficial owner—ideally to the individual level. For opaque structures, require a written declaration from the counterparty with personal liability attached.

3. Sanctions and PEP screening. Run all named individuals (directors, UBOs, major shareholders) and the entity itself through OpenSanctions, OFAC, and the relevant regional lists. Document the screen date and result. Re-screen close to the transaction date.

4. Adverse media. Search counterparty names—entity and key individuals—in English and local language. Check whether the entity or principals appear in court records, regulatory enforcement actions, or investigative journalism.

5. Reference verification. For the references the counterparty provided, actually call them. And for references they didn't provide—former partners, employees, suppliers—try to find and contact those too.

6. Document the file. A diligence file is only useful if it exists. Every search, every result, every date, every source. If you can't show your LP what you checked and when, you didn't really check it.

---

The Honest Reality About What You Can't Know

No diligence process closes every gap. In markets with limited public record infrastructure, some beneficial ownership chains will be genuinely difficult to trace. Some adverse history will be in languages and databases you can't easily access. Some red flags only become visible after the relationship has started.

Acknowledging this isn't defeatist—it's accurate, and it shapes how you use the information you do find. The goal isn't perfect knowledge. It's a documented, proportionate process that demonstrates you looked for the things a reasonable investor would look for, found what was findable, and made a considered judgment about residual risk.

That documented process is also your protection. If a deal goes sideways and regulators or LPs ask what diligence you ran, "we ran a structured counterparty check, screened against OFAC and OpenSanctions, verified beneficial ownership to the UBO level, and documented the results" is a very different conversation than "we relied on the deck and our instincts."

---

What Sentinel Does Here

Sentinel runs structured counterparty checks against public records—corporate registries, sanctions databases, adverse media, and beneficial ownership data—and returns a documented report, not a dashboard score you have to interpret. For a small fund running five to fifteen cross-border deals a year, it's the difference between having a repeatable process and improvising one from scratch each time.

It won't replace local counsel or an in-person reference call. It will tell you, before you pay for either of those things, whether the entity exists, whether the principals are sanctioned, and whether there's adverse history worth digging into. That narrows the problem to a manageable scope before you spend serious time or money on it.